MILTENYI BIOTEC GMBH
Friedrich Ebert Strasse 68 – Bergish Gladbach – 51429
VAT: DE121982110
http://www.miltenyibiotec.com
Complicit EU Projects
Within the Horizon 2020 (2014-2020) framework, MILTENYI BIOTEC GMBH has received € 71,054.0 for its participation in a total of 2 project(s) with a total cost of € 4,347,488.
| Start (YYYYMMDD) | Project ID | Project Name | Themes | End (YYYYMMDD) | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2019-03-01 | 820292 | RESTORE | pharmaceutical drugs · oncology | 2020-07-31 | participant | € 8,750.0 | € 1,000,000 | 1 | 11 | CORDIS ↪ |
| 2018-06-01 | 765104 | MATURE-NK | pharmaceutical drugs · oncology · personalized medicine · business and management · cells technologies | 2022-11-30 | participant | € 62,304.12 | € 3,347,488 | 1 | 14 | CORDIS ↪ |
MILTENYI BIOTEC GMBH did not participate in complicit projects under Horizon Europe (2021-2027).
Within the FP7 (2007-2013) framework, MILTENYI BIOTEC GMBH has received € 1,578,636.0 for its participation in a total of 7 project(s) with a total cost of € 52,612,821.
| Start (YYYYMMDD) | Project ID | Project Name | Themes | End (YYYYMMDD) | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2009-12-01 | 229289 | NANOII | microfluidics · biomolecules · diabetes · autoimmune diseases · transplantation | 2013-11-30 | participant | € 250,000.0 | € 7,390,799 | 3 | 16 | CORDIS ↪ |
| 2009-10-01 | 238778 | ATTRACT | immunology · oncology · employment · cells technologies | 2013-09-30 | participant | € 179,709.08 | € 2,838,539 | 1 | 15 | CORDIS ↪ |
| 2010-11-01 | 261387 | CELL-PID | pharmaceutical drugs · immunology · stem cells · oncology · toxicology | 2016-04-30 | participant | € 395,720.0 | € 15,799,071 | 1 | 20 | CORDIS ↪ |
| 2008-12-01 | 214402 | ANGIOSCAFF | proteins · tissue engineering · carbohydrates · biomaterials | 2012-11-30 | participant | € 203,889.42 | € 15,468,430 | 1 | 33 | CORDIS ↪ |
| 2013-01-01 | 316722 | NEUROKINE | alzheimer · inflammatory diseases · multiple sclerosis · immunology · parkinson | 2017-05-31 | participant | € 146,950.54 | € 3,536,795 | 1 | 13 | CORDIS ↪ |
| 2008-11-01 | 223007 | STAR-T REK | stem cells | 2011-10-31 | participant | € 180,300.0 | € 4,052,900 | 1 | 11 | CORDIS ↪ |
| 2012-10-01 | 317013 | NATURIMMUN | inflammatory diseases · genetic engineering · stem cells · oncology · immunotherapy | 2016-09-30 | participant | € 222,068.88 | € 3,526,286 | 1 | 11 | CORDIS ↪ |